US2006182817A1PendingUtilityA1
Steroidal sapogenins and their derivatives for treating Alzheimer's disease
Est. expiryMar 26, 2018(expired)· nominal 20-yr term from priority
A61P 39/02A61P 39/00A61P 43/00A61P 9/02A61P 9/00A61P 39/06A61P 25/00A61P 25/16A61P 25/18A61P 25/28A61P 21/04A61K 31/704A61K 36/88A61K 31/7048A61K 36/90A61K 36/896A61K 36/8965G01N 33/944A61K 31/58A61K 36/8964A61K 35/00
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention discloses the use of a number of saponins and sapogenins, notably those of steroidal structure, in the treatment of cognitive disfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
Claims
exact text as granted — not AI-modified1 . The use of one or more of smilagenin, prazerigenin, and astragaloside, tigogenin, ruscogenin, hecoginin and diosgenin in the manufacture of a medicament for the treatment of a condition characterised by a deficiency in postsynaptic membrane-bound receptor number or function.
2 - 32 . (canceled)Join the waitlist — get patent alerts
Track US2006182817A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.